About the clinic
Our Trials
Contact us
More
The RESOLVE study is a Phase 1b/2a clinical trial evaluating the safety, tolerability, pharmacokinetics, and efficacy of EP-104GI, an investigational drug, for the treatment of Eosinophilic Esophagitis (EoE).